Publication|Articles|March 14, 2025
- Pharmaceutical Executive: March 2025
- Volume 45
- Issue 2
Pharmaceutical Executive: March 2025 Interactive Digital Edition
View the Pharmaceutical Executive March 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
over 1 year ago
High Impactover 1 year ago
Mark Frohlich: A ‘Natural’ Leaderover 1 year ago
FDA’s New Accelerated Approval Draft Guidanceover 1 year ago
The Virtual Reality of Modern Pharma Sales and MarketingAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
3
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
4
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
5